Literature DB >> 1547825

T cells from atopic individuals produce IgE-inducing activity incompletely blocked by anti-interleukin-4 antibody.

X Zhang1, B Polla, C Hauser, R H Zubler.   

Abstract

We investigated peripheral blood B and T lymphocyte functions in atopic individuals. B cells were co-cultured with mutant EL4 thymoma cells in the presence of a standard T cell supernatant (T-SN) with or without exogenous interleukin (IL)-4. IgE secretion in this assay was found to be IL-4 dependent, but not significantly different for atopic patients (n = 25) vs. normal controls (n = 25). Phytohemagglutinin plus phorbol 12-myristate 13-acetate (PHA+PMA)- induced T-SN from patients or controls was tested on normal B cells in the same assay system (in the absence of exogenous IL-4). Compared to the controls, the IgE-inducing activity was significantly increased for patients with asthma or allergic rhinitis (n = 12; p less than 0.005) but not for patients with atopic dermatitis (n = 13). The difference between the asthma or allergic rhinitis vs. the atopic dermatitis groups was significant (p greater than 0.05). Since the assay was not inhibited by interferon (IFN)-gamma, this difference can not be attributed to IFN-gamma concentrations. Other T cell activities may be different between the patient groups or atopic T cells from the respiratory mucosa may recirculate more than those from the skin. In any case, the T cells rather than the B cells were found to be abnormal in atopic individuals. If atopic T cells were stimulated with PHA+PMA not as immediately but after a resting period of 48 h in culture medium alone, the IgE-inducing activity, but not the total Ig-inducing activity or the IL-2 secretion, disappeared. In addition, a mean of 37% of the IgE-inducing activity (range of 13% to 79% for five very active T-SN) was not inhibited by an anti-IL-4 antibody which neutralized exogenous IL-4, indicating a participation of factors capable of bypassing the requirement for IL-4 for the IgE response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547825     DOI: 10.1002/eji.1830220330

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Molecular biology and genetics of allergy and asthma.

Authors:  G G Anderson; J F Morrison
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

Review 2.  Normal and atopic IgE responses.

Authors:  R H Zubler; X Zhang; A Tucci; B S Polla; C Werner-Favre
Journal:  Springer Semin Immunopathol       Date:  1993

3.  The role of IL-13 in IgE synthesis by allergic asthma patients.

Authors:  T C Van der Pouw Kraan; J S Van der Zee; L C Boeije; E R De Groot; S O Stapel; L A Aarden
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  IgE production in atopic patients is not related to IL-4 production.

Authors:  C T van der Pouw Kraan; R C Aalberse; L A Aarden
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Interleukin 13 is a B cell stimulating factor.

Authors:  T Defrance; P Carayon; G Billian; J C Guillemot; A Minty; D Caput; P Ferrara
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

6.  Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells.

Authors:  H Kimata; M Fujimoto
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.